Inside Wall Street: Four Stocks That Could Double Your Money
10:00 AM 4/5/2011
They may not be household names, but these four companies meet the rigorous investing criteria of these experts. Learn what they are and how they could help you double your money.
A secluded sector of biotechnology -- DNA sequencing and genetic analysis -- is hot once again on Wall Street. Leaders in the sector, like Ilumina, Life Technologies, and Human Genome Sciences, outscored most other biotechs last year.
Inside Wall Street: Bulls Optimistic Despite Disasters and Turmoil
3:00 PM 3/23/2011
Columns, Economy, Investing, Goldman Sachs , Morgan Stanley , Investment
Despite turbulent times, U.S. markets are rising again. But is this a temporary bump, or the return of a bull market? The sharp-eyed analysts of Morgan Stanley and Goldman Sachs say its the latter, and their money is on strong growth ahead.
Inside Wall Street: Turbo-Charged Investment Managing
7:30 AM 3/23/2011
Columns, Economy, Investing, Apple, Bank of America, MasterCard
Wall Street is littered with so-called hot and smart investors who flamed-out during economic downturns or market crashes. But Marketocracy says its investment management teams are different -- with stock picks that have demonstrated proven, long-term staying prowess.
Inside Wall Street: Putting Mergers and Acquisitions to Work for You
9:00 AM 3/19/2011
Investing, Goldman Sachs , Google , Intel, Johnson & Johnson, Apple, Stock Picks, Cisco Systems, Chevron, Market News, Investment
Mergers and acquisitions are becoming ever more popular, with activity up 24% in the first two months of this year -- after already growing 23% in 2010. Here's how your portfolio can benefit from this trend.
Inside Wall Street: Japan Crisis Is a Buying Opportunity for the Stout-Hearted
6:30 AM 3/17/2011
Columns, Economy, Investing, Investing Basics, Market News, Investment
Some investors have been running scared after the quake and tsunami that devastated parts of Japan and left it with an ongoing nuclear crisis. But when there's gloom in the air, there's also opportunity to buy on the dip and gain from the rebound.
As Japan's nuclear crisis deepens, Wall Street may begin to focus on a small group of almost-ignored young biotechs. Known as the bio-defense group, these firms develop products that help protect the population from radiation leaks resulting from nuclear accidents or attacks.
Some stock groups are harder to divine than others, and among those that are tough to figure is the often-opaque insurance industry. But Ray Dirks has been around it for a long time, and when he recommends an insurance stock, it behooves investors to pay attention.
Inside Wall Street: This Tiny Stem Cell Biotech Has the Vatican's Backing
7:30 AM 3/7/2011
Company News, Technology, Columns, Investing, Health Care, Stock Picks
Stem cell research is still too hot for most investors, but NeoStem is starting to change that, thanks to some unexpected events. Among them are the Catholic Church's surprising embrace of NeoStem's research and NeoStem's foothold in China's vast health care market.
Inside Wall Street: How Goldman Is Playing the Coming Tide of Generic Drugs
7:30 AM 3/2/2011
Company News, Columns, Investing, Health Care, Goldman Sachs , Stock Picks
Generic drugs are expected to enjoy a banner year in 2011, prompting some investment pros to reformulate their portfolios to get a jump on the transition. For Goldman Sachs, that means betting on several wholesale distributors and retail drugstores that stand to benefit.
More Stories
Next Page →Market Movers
| Symbol | Last | Change / % | Volume |
|---|
Most Actives
| 8.18 | +0.05 +0.62% | 479.63M | |
| 33.66 | -0.57 -1.67% | 54.64M | |
| 12.69 | -0.15 -1.17% | 52.28M | |
| 2.39 | -0.02 -0.83% | 45.92M |
% Gainers
| 5.90 | +1.00 +20.41% | 25.32M | |
| 10.95 | +1.72 +18.63% | 23.39M | |
| 10.07 | +1.47 +17.09% | 3.66M | |
| 4.01 | +0.57 +16.57% | 807,740 |
% Losers
DailyFinance Wire
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
- Readers' Tips for Financial Renewal, Part 4: Get the Right Job
- Tax Time for Single Parents Can Be Doubly Aggravating
Newswire
- Greek deal to cut spending does not end debt...
- $25B settlement reached over foreclosure abuses
- Stocks close higher after debt deal in Greece
- Euro ministers cold on deal to bail out Greece
- House bans federal lawmakers from insider...
- LinkedIn's 4Q revenue doubles, stock soars 8...
- NRC approves first new nuclear plant in 3...
- 2 Key Ford leaders to retire, Mulally to stay...
- The States With the Most Homes in Foreclosure
- CME Lowers Energy & Metals Margin Trading Requirements (CME, GLD, USO, SLV, JJC)
- LinkedIn 2012 Outlook: EBITDA vs. EPS (LNKD)
- 24/7 Wall St. Closing Bell (AONE, EXPE, RIMM, AMGN, MMM, AAPL, CSCO, AMSC, BG, DNKN, LO, PEP, PM, SIRI, TDC, IPSU, TSL, DMND, GRPN, TLEO, CZR)
- More Short Covering Exaggerates Solar Rallies (TAN, FSLR, SPWR, ENER, TSL, WFR)
- The Case For and Against SIRIUS XM… Value Versus Pandora? (SIRI, P)
- Mid-day Movers (IPSU, DMND, TSL, ARRY, AONE)
- Apple Captures 80% of Mobile Phone Company Profits (AAPL, SSNLF, RIMM, NOK, MMI, GOOG, MSFT)
Follow Us
